86
Views
24
CrossRef citations to date
0
Altmetric
Research Article

Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa

, &
Pages 53-61 | Received 09 Apr 1990, Accepted 08 May 1990, Published online: 27 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Mareike Klinger-Strobel, Christian Lautenschläger, Dagmar Fischer, Jochen G Mainz, Tony Bruns, Lorena Tuchscherr, Mathias W Pletz & Oliwia Makarewicz. (2015) Aspects of pulmonary drug delivery strategies for infections in cystic fibrosis – where do we stand?. Expert Opinion on Drug Delivery 12:8, pages 1351-1374.
Read now
Valerie Waters & Felix Ratjen. (2014) Inhaled liposomal amikacin. Expert Review of Respiratory Medicine 8:4, pages 401-409.
Read now
Yufan Ma, Zhao Wang, Wen Zhao, Tingli Lu, Rutao Wang, Qibing Mei & Tao Chen. (2013) Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium. International Journal of Nanomedicine 8, pages 2351-2360.
Read now
Nicolas Cottenye, Zhong-Kai Cui, Kevin J. Wilkinson, Jean Barbeau & Michel Lafleur. (2013) Interactions between non-phospholipid liposomes containing cetylpyridinium chloride and biofilms of Streptococcus mutans: modulation of the adhesion and of the biodistribution. Biofouling 29:7, pages 817-827.
Read now
Raymond M Schiffelers & Irma AJM Bakker-Woudenberg. (2003) Innovations in liposomal formulations for antimicrobial therapy. Expert Opinion on Therapeutic Patents 13:8, pages 1127-1140.
Read now
E. A. TRAFNY, M. ANTOS-BIELSKA, J. GRZYBOWSKI. (1999) Antibacterial activity of liposom e-encapsulated antibiotics against Pseudomonas aeruginosa attached to the matrix of human dermis. Journal of Microencapsulation 16:4, pages 419-429.
Read now
C. Beaulac, S. Clement-Major, J. Hawari & J. Lagace. (1997) In Vitro Kinetics of Drug Release and Pulmonary Retention of Microencapsulated Antibiotic in Liposomal Formulations in Relation to the Lipid Composition. Journal of Microencapsulation 14:3, pages 335-348.
Read now
Omima A. Sammour & Hosni M. Hassan. (1996) Enhancement of the antibacterial activity of ampicillin by liposome encapsulation. Drug Delivery 3:4, pages 273-278.
Read now

Articles from other publishers (16)

Ali YILMAZ, Nagihan NİZAM, Meltem MACİT, Gülengül DUMAN & Münevver Müge ÇAĞAL. (2023) The preparation, characterization, and antibacterial activity evaluation of nanoliposomes incorporated with terebinth extract. Biotech Studies 32:2, pages 41-48.
Crossref
Chelsea R. Thorn, Cristiane de Souza Carvalho‐Wodarz, Justus C. Horstmann, Claus‐Michael Lehr, Clive A. Prestidge & Nicky Thomas. (2021) Tobramycin Liquid Crystal Nanoparticles Eradicate Cystic Fibrosis‐Related Pseudomonas aeruginosa Biofilms . Small 17:24, pages 2100531.
Crossref
Sayani Bhattacharyya, Preethi Sudheer, Kuntal Das & Subhabrata Ray. (2020) Experimental Design Supported Liposomal Aztreonam Delivery: In Vitro Studies . Advanced Pharmaceutical Bulletin 11:4, pages 651-662.
Crossref
Eline Teirlinck, Alexandre Barras, Jing Liu, Juan C. Fraire, Tatu Lajunen, Ranhua Xiong, Katrien Forier, Chengnan Li, Arto Urtti, Rabah Boukherroub, Sabine Szunerits, Stefaan C. De Smedt, Tom Coenye & Kevin Braeckmans. (2019) Exploring Light-Sensitive Nanocarriers for Simultaneous Triggered Antibiotic Release and Disruption of Biofilms Upon Generation of Laser-Induced Vapor Nanobubbles. Pharmaceutics 11:5, pages 201.
Crossref
M.C. Teixeira, E. Sanchez-Lopez, M. Espina, A.C. Calpena, Amelia M. Silva, F.J. Veiga, M.L. Garcia & Eliana B. Souto. 2018. Emerging Nanotechnologies in Immunology. Emerging Nanotechnologies in Immunology 233 259 .
Angélique Mottais, Tony Le Gall, Yann Sibiril, Julian Ravel, Véronique Laurent, Frédérique d’Arbonneau & Tristan Montier. (2017) Enhancement of lung gene delivery after aerosol: a new strategy using non-viral complexes with antibacterial properties. Bioscience Reports 37:6.
Crossref
Kamal Dua, Shakti D. Shukla, Rakesh K. Tekade & Philip M. Hansbro. (2016) Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?. Drug Delivery and Translational Research 7:1, pages 179-187.
Crossref
Sagar Dhoble, Vinod Ghodake, Manasi Chogale & Vandana Patravale. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy 457 480 .
N. Škalko-Basnet & Ž. Vanić. 2017. Functionalized Nanomaterials for the Management of Microbial Infection. Functionalized Nanomaterials for the Management of Microbial Infection 111 152 .
Kunn Hadinoto & Wean Sin Cheow. (2014) Nano-antibiotics in chronic lung infection therapy against Pseudomonas aeruginosa. Colloids and Surfaces B: Biointerfaces 116, pages 772-785.
Crossref
Shigeru Kohno, Kazunori Tomono & Shigefumi Maesaki. (1998) Drug Delivery Systems for Infection: Liposome-Incorporating Antimicrobial Drugs. Journal of Infection and Chemotherapy 4:4, pages 159-173.
Crossref
Mohamed Laakel, Martin Bouchard & Jacqueline Lagacé. (1996) Measurement of mouse anti-phospholipid antibodies to solid-phase microspheres by both flow cytofluorometry and Alcian blue-pretreated microtitre plates in an ELISA. Journal of Immunological Methods 190:2, pages 267-273.
Crossref
C BeaulacS Clément-MajorJ HawariJ Lagacé. (1996) Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection. Antimicrobial Agents and Chemotherapy 40:3, pages 665-669.
Crossref
M. Antos, E. A. Trafny & J. Grzybowski. (1996) The influence ofPseudomonas aeruginosa on liposomes. Folia Microbiologica 41:1, pages 29-32.
Crossref
Malgorzata Antos, Elzbieta Anna Trafny & Jacek Grzybowski. (1995) Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro. Pharmacological Research 32:1-2, pages 85-87.
Crossref
A OmriC BeaulacM BouhajibS MontplaisirM SharkawiJ Lagacé. (1994) Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 38:5, pages 1090-1095.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.